Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250)
South Korea flag South Korea · Delayed Price · Currency is KRW
239,500
+12,000 (5.27%)
At close: Dec 10, 2025

Sam Chun Dang Pharm. Revenue

Sam Chun Dang Pharm. had revenue of 58.02B KRW in the quarter ending September 30, 2025, with 10.77% growth. This brings the company's revenue in the last twelve months to 220.74B, up 6.01% year-over-year. In the year 2024, Sam Chun Dang Pharm. had annual revenue of 210.92B with 9.47% growth.

Revenue (ttm)
220.74B
Revenue Growth
+6.01%
P/S Ratio
23.97
Revenue / Employee
523.07M
Employees
422
Market Cap
5.29T

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024210.92B18.26B9.47%
Dec 31, 2023192.67B15.33B8.65%
Dec 31, 2022177.34B10.06B6.01%
Dec 31, 2021167.27B412.57M0.25%
Dec 31, 2020166.86B-19.74B-10.58%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Samsung Biologics5.50T
Celltrion3.90T
Yuhan2.14T
Hanmi Pharm.1.47T
SK Biopharmaceuticals675.41B
ALTEOGEN202.18B
LigaChem Biosciences159.27B
ABL Bio88.44B
Revenue Rankings